semaglutide fda approval mash GLP-1 BREAKTHROUGH: APPROVES TREATMENT FOR SERIOUS LIVER DISEASE Semaglutide, a medication already known for its role in weight management, is now the first GLP-1 therapy approved to treat (Metabolic Dysfunction–Associated FDA approves Wegovy for liver

According to a press release by Novo, current Hims patients will also have the opportunity to transition to FDA-approved alternatives when clinically appropriate in consultation with a health care professional. FDA Commissioner Makary posted the following on X (formerly Twitter) : Glad to see HIMS will stop advertising unapproved compounded drugs and instead sell FDA-approved products through its new partnership with Novo Nordisk

Hoffmann K, Emons B, Brunnhuber S, Karaca S, Juckel G

It is a material difference in what the patient is actually injecting

10.1016/j.molcel.2018.10.042 40 GascnS.MurenuE.MasserdottiG.OrtegaF.RussoG

10.1111/j.1365-313X.2007.03280.x 29 MeyerA